sodium polystyrene sulfonate 250 MG/ML Oral Suspension
RxNorm concept 313072, clinical drug (scd). Prescribable name: sodium polystyrene sulfonate 15 GM in 60 mL Oral or Rectal Suspension.
- RxCUI
- 313072
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/313072 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
sodium polystyrene sulfonate 15 GM per 60 ML Oral Suspension; sodium polystyrene sulfonate 30 GM per 120 ML Oral Suspension
Related concepts
- sodium polystyrene sulfonate 250 MG/ML (SCDC, consists of)
- Oral Suspension (DF, has dose form)
- sodium polystyrene sulfonate 250 MG/ML Oral Suspension [Kionex] (SBD, has tradename)
- sodium polystyrene sulfonate 250 MG/ML Oral Suspension [SPS] (SBD, has tradename)
Linked data
NDCs
- 00054037950
- 00054037951
- 00054037955
- 00054037963
- 35573010813
- 35573010814
- 35573010857
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 313072 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/313072 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 313072. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.